Search for Clinical Trial Results
Pyoderma Gangrenosum - 17 Studies Found
Status | Study |
Completed |
Study Name: Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease Condition:
|
Completed |
Study Name: Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease Condition: Crohn Disease Date: 2010-11-02 Interventions: Drug: Tacrolimus Once daily application for 12 weeks followed by 4 weeks observation. Optional 36 week o |
RECRUITING |
Study Name: Spesolimab in Pyoderma Gangrenosum Condition: Pyoderma Gangrenosum Date: 2024-05-12 Interventions: 900 mg of spesolimab intravenously (IV) administered at Weeks 0, 3, 6, 9, 12 and 15. |
RECRUITING |
Study Name: Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG) Condition: Pyoderma Gangrenosum Date: 2024-05-12 Interventions: Subjects with PG will be treated with 4 mg once daily of baricitinib for 24 weeks. |
NOT_YET_RECRUITING |
Study Name: Deucravacitinib in PG Condition: Pyoderma Gangrenosum Date: 2024-05-12 Interventions: 6 mg tablet |
RECRUITING |
Study Name: Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum Condition: Pyoderma Gangrenosum Date: 2024-05-12 Interventions: vilobelimab infusion |